Stefan Michiels

2003–2025 年に発表

154
論文数
27,881
被引用数
84
h 指数
146
i10 指数

被引用数

Stefan Michiels の年別被引用数1986 年: 被引用 1 件1987 年: 被引用 1 件1999 年: 被引用 2 件2003 年: 被引用 3 件2004 年: 被引用 2 件2005 年: 被引用 30 件2006 年: 被引用 69 件2007 年: 被引用 88 件2008 年: 被引用 104 件2009 年: 被引用 93 件2010 年: 被引用 125 件2011 年: 被引用 91 件2012 年: 被引用 130 件2013 年: 被引用 142 件2014 年: 被引用 209 件2015 年: 被引用 268 件2016 年: 被引用 298 件2017 年: 被引用 325 件2018 年: 被引用 333 件2019 年: 被引用 1,001 件2020 年: 被引用 1,331 件2021 年: 被引用 1,420 件2022 年: 被引用 1,206 件2023 年: 被引用 937 件2024 年: 被引用 1,453 件2025 年: 被引用 762 件2026 年: 被引用 43 件1988〜1998 年は被引用が無いため表示していません2000〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,919 件、この内訳の 20%中国: 引用元論文 1,426 件、この内訳の 9.8%フランス: 引用元論文 991 件、この内訳の 6.8%イタリア: 引用元論文 986 件、この内訳の 6.8%イギリス: 引用元論文 834 件、この内訳の 5.7%ドイツ: 引用元論文 810 件、この内訳の 5.5%スペイン: 引用元論文 534 件、この内訳の 3.7%ベルギー: 引用元論文 489 件、この内訳の 3.3%オーストラリア: 引用元論文 471 件、この内訳の 3.2%オランダ: 引用元論文 450 件、この内訳の 3.1%カナダ: 引用元論文 408 件、この内訳の 2.8%日本: 引用元論文 405 件、この内訳の 2.8%
0%20%その他 26.5%

分野

  • Medicine56.1%
  • Biochemistry, Genetics and Molecular Biology32.1%
  • Immunology and Microbiology5%
  • Computer Science2.8%
  • Mathematics1%
  • Engineering0.7%
  • その他2.3%

トピック

  • Cancer Immunotherapy and Biomarkers8.7%
  • Cancer Genomics and Diagnostics6.4%
  • Breast Cancer Treatment Studies4.4%
  • Cancer Cells and Metastasis4.1%
  • Immunotherapy and Immune Responses3.8%
  • Lung Cancer Treatments and Mutations2.7%
  • その他69.9%

共著者

全論文

検索で開く
  1. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2020 被引用: 1,188

  2. CD4+ follicular helper T cell infiltration predicts breast cancer survival

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2013 被引用: 1,050

  3. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 891

  4. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  5. Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 被引用: 1,647

  6. High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander M.M. Eggermont, Fabrice André, Jean‐Charles Soria - Cancer Discovery 2017 被引用: 776

  7. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2024 被引用: 345

  8. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    著者: , , , , , , , , , , , , , , , - Annals of Oncology 2014 被引用: 1,270

  9. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard‐Gallo, An Coosemans, Edith Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M.S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, W. Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernán Garcı́a Rivello, Hugo M. Horlings, Saïd Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group, Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Veronica Bautista ほか 454 名 - npj Breast Cancer 2021 被引用: 275

  10. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 720

  11. Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 464

  12. The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition

    著者: , , , , , , - Annals of Oncology 2021 被引用: 271

  13. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wolfgang Janni, Elisabetta Munzone, Vicente Carañana, Sofia Agelaki, Camillo Almici, Luc Dirix, Erich‐Franz Solomayer, Laura Zorzino, Helene Johannes, Jorge S. Reis‐Filho, Klaus Pantel, Jean‐Yves Pierga, Stefan Michiels - The Lancet Oncology 2014 被引用: 838

  14. Biomarker Discovery and Validation: Statistical Considerations

    著者: , , , , - Journal of Thoracic Oncology 2021 被引用: 232

  15. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabine C. Linn, Matthew P. Goetz, Stefan Michiels, International Immuno-Oncology Biomarker Working Group - JAMA 2024 被引用: 199

  16. Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab

    著者: , , , , , , , , , , , , , , - JAMA Oncology 2015 被引用: 606

  17. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Seminars in Cancer Biology 2017 被引用: 432

  18. Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges

    著者: , , , , , , , , , , , - BMC Medicine 2023 被引用: 88

  19. High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paolo Nucíforo, Rodrigo Dienstmann, Chandra Verma, Núria López-Bigas, Maurizio Scaltriti, Mónica Arnedos, Cristina Saura, Violeta Serra - Nature Communications 2022 被引用: 120

  20. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen van der Laak, Francesco Ciompi, Anne‐Vibeke Lænkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H. Beck, J. Kaplan Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin T. Hiley, Maise Al Bakir, Alexander J. Lazar, Stephen P. Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria Vittoria Dieci, Fabrice André, Charles Swanton, Jorge S. Reis‐Filho, Joseph A. Sparano, Eva Balslev, I‐Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine L. Pogue–Geile, Kim Blenman, Frédérique Penault–Llorca, Stuart J. Schnitt, Sunil R. Lakhani, Anne Vincent‐Salomon, Federico Rojo, Jeremy Braybrooke, Matthew G. Hanna, María Teresa Soler-Monsó, Daniel Bethmann, Carlos Castaneda, Karen Willard‐Gallo, Ashish Sharma, Huang‐Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I. González-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David Moore, Roberto Salgado, the International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo ほか 156 名 - npj Breast Cancer 2020 被引用: 206

  21. Resistance to Selective FGFR Inhibitors in FGFR- Driven Urothelial Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 被引用: 76

  22. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Proudhon, Denise M. Wolf, Jessica B. Bauldry, Elin Borgen, Rin Nagaoka, Vicente Carañana, Jaco Kraan, Marisa Maestro, Sara Y. Brucker, Karsten E. Weber, Fabien Reyal, Dominic Amara, Mandar Karhade, Randi R. Mathiesen, H. Tokiniwa, Antonio Llombart‐Cussac, Alessandra Meddis, Paul Blanche, Koenraad D’Hollander, Paul Cottu, John W. Park, Sibylle Loibl, Aurélien Latouche, Jean‐Yves Pierga, Klaus Pantel - JNCI Journal of the National Cancer Institute 2018 被引用: 282

  23. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul J. van Diest, Marjanka K. Schmidt, Marleen Kok, Gwen M.H.E. Dackus, Roberto Salgado, Sabine C. Linn - Journal of Clinical Oncology 2022 被引用: 144

  24. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. J. van Diest - 2022 被引用: 103